002198 嘉应制药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资25,314-6.57%27,09429,37930,59058,267
投资性房地产0--0000
固定资产181,059-4.07%188,748203,703224,189245,780
在建工程6,706303.73%1,661000
无形资产46,550-1.39%47,20852,37558,29364,163
商誉0--0000
其他非流动资产17,164540.93%2,6783,7624,5935,709
276,7923.52%267,389289,218317,665373,920

流动资产
货币资金171,51928.47%133,507183,858239,385142,236
应收账款99,0251.48%97,585146,02796,867113,606
存货97,43215.17%84,60082,28573,35772,799
其他流动资产171,277-35.24%264,482145,26380,065105,879
539,254-7.05%580,174557,433489,673434,520

流动负债
短期借款0--0031,10520,164
应付票据0--0000
应付帐款13,90751.89%9,15618,97514,12410,297
其他流动负债23,740-40.92%40,18363,97242,68259,997
37,647-23.70%49,33982,94787,91190,458
流动资产净值501,607-5.51%530,835474,485401,761344,063
资产总额减流动负债778,399-2.48%798,224763,704719,426717,982

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债35,122-0.33%35,24035,28634,94334,976
35,122-0.33%35,24035,28634,94334,976

总权益
    实收股本507,5100.00%507,510507,510507,510507,510
    储备项目235,767-7.71%255,475220,908176,973175,496
股东权益743,277-2.58%762,985728,418684,483683,006
非控股权益0--0000